AzTrials
AzTrials

Jaw, Edentulous, PartiallyPhase 4NCT06294249

Pain Severity in Flapless Dental Implant Placement Using Laser

A Phase 4 study testing Laser-induced Incision, Punch Incision and Implant Placement in people with Jaw, Edentulous, Partially, run by Shiraz University of Medical Sciences at 1 site in Iran.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this split-mouth randomized clinical trial study was to investigate the effect of using a laser on pain and discomfort following flapless dental implant surgery. It was hypothesized that laser did not have any impact on post-op pain. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Jaw, Edentulous, Partially
What is being tested?
Laser-induced Incision, Punch Incision and Implant Placement
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteIran
Study dates
1 Jan 2020to 4 Dec 2023
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Adult human subjects agreed to participate in the study and return on follow-up times
  • Subjects eligible for receiving dental implants
  • Subjects with an edentulous area in the posterior of the mandible bilaterally 3- Subjects with sufficient bone width and height (>5 mm width, and >10 mm height) at the implant sites
  • Subjects with sufficient keratinization tissue at the implant sites

Who cannot join

  • Subjects refused to return for follow-up or refused study enrollment.
  • Subjects with uncontrolled systemic diseases
  • Subjects younger than 18 years
  • Subjects receiving psychotropic drugs

Trial locations and contacts

1 site in 1 country.

Iran1 site
  • shiraz University of medical sciences

    Shiraz, Fars

Other trials in Iran

About this study

Official title: The Evaluation of Pain Severity in Flapless Dental Implant Placement Using Laser-induced Incisions: A Split Mouth Randomized Clinical Trial Study

The goal of this split-mouth randomized clinical trial study was to investigate the effect of using a laser on pain and discomfort following flapless dental implant surgery. It was hypothesized that laser did not have any impact on post-op pain. Therefore, the study aimed to compare pain and discomfort following flapless dental implant surgeries with or without a laser.

Being tested
Laser-induced Incision, Punch Incision, Implant Placement
Keywords
Jaw, Edentulous, Partially, Pain Measurement, Laser Therapy, Dental Implants, Randomized Controlled Trial
Medical subject headings
Jaw, Edentulous, Partially

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Laser-induced IncisionDevice

    On the treatment side, an incision was made on the crest of the alveolar soft tissue using the laser.

  • Punch IncisionProcedure or surgery

    On the control side, a punch incision was made on the crest of the alveolar soft tissue using using a punch.

  • Implant PlacementProcedure or surgery

    Implant placement was done in both laser and punch arms. The drilling was performed based on the company (Straumman) protocol. On each side, a dental implant (Straumman SP, Basel, Switzerland) and healing abutment were placed. Patients were visited at 24, 48, 72 hours, and 7 days after insertion.

Study groups in NCT06294249
Study groupRoleWhat they receive
Laser-induced IncisionExperimentalThe Biolase Epic 10 diode laser device (Biolase, USA) with 940 nm wavelength, 10 W of max output power, 20 KHz of pulse repetition rate, and continuous pulse mode was used.
Receives: Device: Laser-induced Incision; Procedure: Implant Placement
Punch IncisionActive comparatorThe soft tissue Osstem punch (South Korea) was used.
Receives: Procedure: Punch Incision; Procedure: Implant Placement

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain Severity

    Measured using the visual analogue scale (VAS): 0-3 mild pain, 4-6 moderate pain, and 7-10 sever pain.

    Measured: Patients were visited at 24, 48, 72 hours, and 7 days after insertion.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Mar 2024
  2. Study start1 Jan 2020
  3. Primary completion1 Dec 2023
  4. Study completion4 Dec 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06294249
Sponsor's protocol ID
20045125
Status last verified
Mar 2024
First submitted
22 Jan 2024
Last updated
26 Mar 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Laser-induced Incision, Punch Incision and Implant Placement in people with Jaw, Edentulous, Partially, run by Shiraz University of Medical Sciences at 1 site in Iran.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Iran. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain Severity (time frame: Patients were visited at 24, 48, 72 hours, and 7 days after insertion.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Mar 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in